http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24818257

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 79
issn 0028-3878
1526-632X
issueIdentifier 1
pageRange 73-79
publicationName Neurology
startingPage 73
bibliographicCitation O'Connor P, Comi G, Montalban X, Antel J, Radue EW, de Vera A, Pohlmann H, Kappos L; FTY720 D2201 Study Group. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology. 2009 Jan 06;72(1):73–9. doi: 10.1212/01.wnl.0000338569.32367.3d. PMID: 19122034.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b42eaddbcba3dc4840909557c10d653
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7faaf99406936a8ef9e81d0a5f132d74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b4ad2bc5a0ce2fa625fb67866985bc7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c774c9cd4b686c59a783cd20f2dcc31
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd1444513a235ee7516eaeef8ed4c41f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_252268b225bcfa5e6d44eda8207d3c75
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20bca7be070d24e00bf07df7c8011625
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e84e15c38d77060455da3734c667a02
date 2009-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19122034
https://doi.org/10.1212/01.wnl.0000338569.32367.3d
isPartOf https://portal.issn.org/resource/ISSN/0028-3878
https://portal.issn.org/resource/ISSN/1526-632X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6069
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study
discusses http://id.nlm.nih.gov/mesh/M0020302
http://id.nlm.nih.gov/mesh/M0011171
http://id.nlm.nih.gov/mesh/M0259274
http://id.nlm.nih.gov/mesh/M0017742
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009103Q000188
http://id.nlm.nih.gov/mesh/D011409Q000008
http://id.nlm.nih.gov/mesh/D007166Q000008
http://id.nlm.nih.gov/mesh/D013110Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D013110Q000008
http://id.nlm.nih.gov/mesh/D012720
http://id.nlm.nih.gov/mesh/D000068876
http://id.nlm.nih.gov/mesh/D012129Q000379
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D008279
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D009103Q000401
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D004185
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D015994
http://id.nlm.nih.gov/mesh/D053208
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107970

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129060975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129645792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128394615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136111139

Total number of triples: 61.